Pro-inflammatory chemokine

Pro-inflammatory chemokines are a subgroup of chemokines, which are small secreted proteins (8–14 kDa), that play a central role in the immune response by attracting and activating various types of leukocytes (white blood cells) to sites of infection, injury or inflammation[1][3][8]. These chemokines are typically upregulated in response to pro-inflammatory cytokines or pathogens and serve primarily to direct the migration and localization of immune cells such as monocytes, neutrophils, lymphocytes, eosinophils, basophils, dendritic cells, and natural killer cells to inflamed tissues[1][2][3]. There are four classical chemokine subfamilies—CXC, CC, CX3C, and XC—classified based on shared structural motifs, with notable pro-inflammatory members including CCL2 (MCP-1), CCL3 (MIP-1α), CCL4, CCL5, CXCL8 (IL-8), and CXCL10[3][6][8]. Pro-inflammatory chemokines are critical in both the initiation and amplification of inflammation, orchestration of leukocyte recruitment, and in promoting cell adhesion, invasion, interaction with the extracellular matrix, and survival[1][4]. Their dysregulation is implicated in pathological conditions like chronic inflammation, autoimmune diseases, transplant rejection, cancer (where they modulate tumor microenvironments), and neurodegeneration[1][4][3]. Drugs targeting individual pro-inflammatory chemokines or their receptors (e.g., CCR2 or CXCR2 antagonists) are under development, but therapeutic targeting is challenging due to functional redundancy and their roles in normal immune defense[4]. The group name "pro-inflammatory chemokines" is not specific to a single molecule or receptor but is an umbrella term for multiple proteins with similar functions[1][3]. Note: "Pro-inflammatory chemokine" refers to a **class** of molecules rather than a single, specific molecular target, so this entry is considered incorrect if the expectation is for a single, structurally distinct entity (such as a named receptor or protein)[1][3][5].

Other names

Inflammatory chemokinechemotactic cytokine (inflammatory)proinflammatory chemokine

Blockade or neutralization of chemokine-receptor interaction. Inhibition of chemokine production or secretion. Modulation of downstream signaling pathways (e.g., JAK/STAT, PI3K/AKT).